MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health ROA Ratio 2011-2026 | OPK
Annual ROA Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.64 | -3.3 | -15.15 | -1.26 | 1.24 | -13.64 | -6.24 | -11.95 | -0.91 | -1.07 | -13.54 | -8.22 | -10.02 | -0.56 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.24 | -15.15 | -6.0 |
Quarterly ROA Ratio OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.12 | -6.74 | -7.67 | -9.68 | -10.0 | -9.73 | -9.49 | -10.98 | -8.68 | -11.75 | -4.29 | -4.96 | -1.32 | 3.06 | 2.83 | 4.86 | 1.24 | -4.93 | -8.58 | -12.53 | -13.64 | -11.88 | -10.32 | -7.98 | -6.24 | -11.55 | -11.81 | -12.21 | -11.79 | -4.16 | -3.31 | -2.1 | -1.2 | -0.36 | 4.77 | 2.66 | -1.12 | -5.4 | -13.82 | -14.28 | -13.58 | -10.62 | -11.09 | -9.32 | -8.27 | -7.4 | -6.41 | -9.7 | -10.22 | -2.04 | -2.3 | -1.27 | -0.79 | -3.59 | -2.5 | -2.49 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.86 | -14.28 | -6.37 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
-44.15 | $ 15.17 | 3.27 % | $ 1.97 B |  USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.12 | -0.47 % | $ 4.87 M | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 74.9 | -1.1 % | $ 5.05 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Medpace Holdings
MEDP
|
22.84 | $ 459.32 | 0.52 % | $ 13.2 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.78 | 2.47 % | $ 443 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.42 | -0.51 % | $ 390 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 159.35 | 0.79 % | $ 7.9 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 164.84 | -1.3 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.18 | -19.01 % | $ 6.43 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 259.61 | 1.55 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 125.09 | 1.05 % | $ 19.9 B | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.4 | 0.36 % | $ 420 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
-32.34 | $ 26.8 | -0.48 % | $ 34.8 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 7.82 | 2.76 % | $ 463 M | USA |
 |
Celcuity
CELC
|
-45.6 | $ 103.35 | -3.19 % | $ 4.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 265.46 | 0.37 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
RadNet
RDNT
|
-0.5 | $ 59.99 | -2.84 % | $ 4.51 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 3.36 | -3.45 % | $ 1.8 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.03 | -0.86 % | $ 1.03 B | USA |
 |
Natera
NTRA
|
-39.28 | $ 195.57 | -2.26 % | $ 19.2 B | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.73 | 1.59 % | $ 281 M | USA |
 |
Sotera Health Company
SHC
|
2.39 | $ 13.88 | -0.04 % | $ 3.94 B | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.57 | 0.06 % | $ 936 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 25.42 | -1.28 % | $ 706 M | USA |
 |
Neuronetics
STIM
|
-27.55 | $ 1.48 | -7.81 % | $ 97.6 M | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 7.5 | 0.03 % | $ 29.9 M | Israel |
 |
DexCom
DXCM
|
13.19 | $ 66.27 | 0.5 % | $ 25.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | $ 104.91 | - | $ 19.8 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |